SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
21-Jun-24 4:01 PM View: | SCYNEXIS, Inc. (SCYX) | 20-Jun-24 | Grant | 23,000 | -- | -- | 97% 23.62K to 46.62K | |
23-Jun-23 4:10 PM View: | SCYNEXIS, Inc. (SCYX) | 15-Jun-23 | Grant | 10,000 | -- | -- | 73% 13.62K to 23.62K | |
22-Jun-22 4:04 PM View: | SCYNEXIS, Inc. (SCYX) | 17-Jun-22 | Grant | 10,000 | -- | -- | 276% 3.62K to 13.62K | |
23-Dec-20 9:07 AM View: | SCYNEXIS, Inc. (SCYX) | 21-Dec-20 | Market Purchase | 3,200 | $6.25 | $20,000.00 | 758% 0.42K to 3.62K | 6% |
16-Aug-19 4:24 PM View: | Htg Molecular Diagnostics, ... (HTGM) | 14-Aug-19 | Grant | 2,500 | -- | -- | 52% 4.8K to 7.3K | |
12-Sep-18 8:04 PM View: | Htg Molecular Diagnostics, ... (HTGM) | 11-Sep-18 | Grant | 2,304 | $4.34 | $9,999.36 | 92% 2.5K to 4.8K | (94%) |
17-Aug-18 5:23 PM View: | Htg Molecular Diagnostics, ... (HTGM) | 15-Aug-18 | Grant | 2,500 | -- | -- | 100% 0 to 2.5K | |
05-May-17 5:09 PM View: | Endocyte, Inc. (ECYT) | 04-May-17 | Grant | 3,300 | -- | -- | 73% 4.5K to 7.8K | |
27-May-16 1:53 PM View: | SCYNEXIS, Inc. (SCYX) | 25-May-16 | Market Purchase | 4,225 | $3.64 | $15,379.00 | 100% 0 to 4.22K | (84%) |
06-May-16 4:46 PM View: | Endocyte, Inc. (ECYT) | 05-May-16 | Grant | 2,250 | -- | -- | 100% 2.25K to 4.5K | |
18-May-15 4:34 PM View: | Endocyte, Inc. (ECYT) | 14-May-15 | Grant | 2,250 | -- | -- | 100% 0 to 2.25K | |
29-May-13 4:20 PM View: | Endocyte, Inc. (ECYT) | 28-May-13 | Market Sale | 1,700 | $14.25 | $24,225.00 | (< 1%) 707.13K to 705.43K | (69%) |
29-May-13 4:20 PM View: | Endocyte, Inc. (ECYT) | 24-May-13 | Market Sale | 8,200 | $14.07 | $115,374.00 | (1%) 715.34K to 707.13K | (71%) |
22-May-13 6:30 PM View: | Endocyte, Inc. (ECYT) | 22-May-13 | Market Sale | 16,400 | $14.39 | $235,996.00 | (2%) 731.74K to 715.34K | (68%) |
22-May-13 6:30 PM View: | Endocyte, Inc. (ECYT) | 21-May-13 | Market Sale | 11,000 | $14.31 | $157,410.00 | (1%) 742.74K to 731.74K | (69%) |
22-May-13 6:30 PM View: | Endocyte, Inc. (ECYT) | 20-May-13 | Market Sale | 12,600 | $14.42 | $181,692.00 | (2%) 755.34K to 742.74K | (67%) |
20-May-13 4:38 PM View: | Endocyte, Inc. (ECYT) | 17-May-13 | Market Sale | 14,600 | $14.37 | $209,802.00 | (2%) 769.93K to 755.34K | (68%) |
20-May-13 4:38 PM View: | Endocyte, Inc. (ECYT) | 16-May-13 | Market Sale | 22,600 | $14.44 | $326,344.00 | (3%) 792.53K to 769.93K | (67%) |
16-May-13 5:16 PM View: | Endocyte, Inc. (ECYT) | 15-May-13 | Market Sale | 20,000 | $14.43 | $288,600.00 | (2%) 812.53K to 792.53K | (67%) |
16-May-13 5:16 PM View: | Endocyte, Inc. (ECYT) | 14-May-13 | Market Sale | 20,200 | $14.94 | $301,788.00 | (2%) 832.74K to 812.53K | (61%) |
07-Jun-12 4:18 PM View: | Endocyte, Inc. (ECYT) | 06-Jun-12 | Market Sale | 314,900 | $6.60 | $2,079,380.00 | (27%) 1.15M to 832.74K | (265%) |
07-Jun-12 4:18 PM View: | Endocyte, Inc. (ECYT) | 05-Jun-12 | Market Sale | 10,200 | $6.60 | $67,349.60 | (< 1%) 1.16M to 1.15M | (265%) |
18-May-12 4:09 PM View: | Endocyte, Inc. (ECYT) | 16-May-12 | Market Sale | 27,900 | $6.65 | $185,552.00 | (2%) 1.23M to 1.2M | (262%) |
16-May-12 5:48 PM View: | Endocyte, Inc. (ECYT) | 15-May-12 | Market Sale | 40,000 | $6.68 | $267,148.00 | (3%) 1.23M to 1.19M | (261%) |
16-May-12 5:48 PM View: | Endocyte, Inc. (ECYT) | 14-May-12 | Market Sale | 107,000 | $6.94 | $742,088.00 | (8%) 1.33M to 1.23M | (247%) |
11-Feb-11 5:43 PM View: | Endocyte, Inc. (ECYT) | 09-Feb-11 | Conversion | 832,735 | -- | -- | 167% 500.0K to 1.33M | |
08-Feb-11 8:17 PM View: | Endocyte, Inc. (ECYT) | 04-Feb-11 | Grant | 500,000 | $6.00 | $3,000,000.00 | 100% 0 to 500.0K | 301% |
15-May-06 6:22 PM View: | BioMimetic Therapeutics Inc. (BMTI) | 11-May-06 | Conversion Duplicate | 2,353,430 | -- | -- | 100% 0 to 2.35M | |
18-Apr-06 3:48 PM View: | Targacept, Inc. (GYRE) | 18-Apr-06 | Conversion | 778,062 | -- | -- | 77806% 1.0K to 779.06K | |
23-Apr-04 10:00 PM View: | Immunicon Corp (IMMCQ.PK) | 21-Apr-04 | Option Exercise | 1,166,670 | -- | -- | 100% 0 to 1.17M |